Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.

The loss of dopaminergic (DA) neurons in the substantia nigra (SN) is a major pathophysiological feature of patients with Parkinson's disease (PD). As nigral DA neurons contain both neuromelanin (NM) and dopamine transporter (DAT), decreased intensities in both NM-sensitive MRI and DAT PET refl...

Full description

Bibliographic Details
Main Authors: Hiroshi Kawaguchi, Hitoshi Shimada, Fumitoshi Kodaka, Masayuki Suzuki, Hitoshi Shinotoh, Shigeki Hirano, Jeff Kershaw, Yuichi Inoue, Masaki Nakamura, Taeko Sasai, Mina Kobayashi, Tetsuya Suhara, Hiroshi Ito
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4783074?pdf=render
id doaj-adb82eb750014f7a8efe6f763ccc4475
record_format Article
spelling doaj-adb82eb750014f7a8efe6f763ccc44752020-11-25T01:58:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015119110.1371/journal.pone.0151191Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.Hiroshi KawaguchiHitoshi ShimadaFumitoshi KodakaMasayuki SuzukiHitoshi ShinotohShigeki HiranoJeff KershawYuichi InoueMasaki NakamuraTaeko SasaiMina KobayashiTetsuya SuharaHiroshi ItoThe loss of dopaminergic (DA) neurons in the substantia nigra (SN) is a major pathophysiological feature of patients with Parkinson's disease (PD). As nigral DA neurons contain both neuromelanin (NM) and dopamine transporter (DAT), decreased intensities in both NM-sensitive MRI and DAT PET reflect decreased DA neuronal density. This study demonstrates that a more specific metric for the nigral DA neuronal density can be derived with multimodal MRI and PET. Participants were 11 clinically diagnosed PD patients and 10 age and gender matched healthy controls (HCs). Two quantities, the NM-related index (RNM) and the binding potential of the radiotracer [18F]FE-PE2I to DAT (BPND) in SN, were measured for each subject using MRI and PET, respectively. Principal component analysis (PCA) was applied to the multimodal data set to estimate principal components. One of the components, PCP, corresponds to a basis vector oriented in a direction where both BPND and RNM increase. The ability of BPND, RNM and PCP to discriminate between HC and PD groups was compared. Correlation analyses between the motor score of the unified Parkinson's disease rating scale and each metric were also performed. PCP, BPND and RNM for PD patients were significantly lower than those for HCs (F = 16.26, P<0.001; F = 6.05, P = 0.008; F = 7.31, P = 0.034, respectively). The differential diagnostic performance between the HC and PD groups as assessed by the area under the receiver-operating characteristic curve was best for PCP (0.94, 95% CI: 0.66-1.00). A significant negative correlation was found between the motor severity score and PCp (R = -0.70, P<0.001) and RNM (R = -0.52, P = 0.015), but not for BPND (R = -0.36, P = 0.110). PCA of multimodal NM-sensitive MRI and DAT PET data provides a metric for nigral DA neuronal density that will help illuminate the pathophysiology of PD in SN. Further studies are required to explore whether PCA is useful for other parkinsonian syndromes.http://europepmc.org/articles/PMC4783074?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Hiroshi Kawaguchi
Hitoshi Shimada
Fumitoshi Kodaka
Masayuki Suzuki
Hitoshi Shinotoh
Shigeki Hirano
Jeff Kershaw
Yuichi Inoue
Masaki Nakamura
Taeko Sasai
Mina Kobayashi
Tetsuya Suhara
Hiroshi Ito
spellingShingle Hiroshi Kawaguchi
Hitoshi Shimada
Fumitoshi Kodaka
Masayuki Suzuki
Hitoshi Shinotoh
Shigeki Hirano
Jeff Kershaw
Yuichi Inoue
Masaki Nakamura
Taeko Sasai
Mina Kobayashi
Tetsuya Suhara
Hiroshi Ito
Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
PLoS ONE
author_facet Hiroshi Kawaguchi
Hitoshi Shimada
Fumitoshi Kodaka
Masayuki Suzuki
Hitoshi Shinotoh
Shigeki Hirano
Jeff Kershaw
Yuichi Inoue
Masaki Nakamura
Taeko Sasai
Mina Kobayashi
Tetsuya Suhara
Hiroshi Ito
author_sort Hiroshi Kawaguchi
title Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
title_short Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
title_full Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
title_fullStr Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
title_full_unstemmed Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
title_sort principal component analysis of multimodal neuromelanin mri and dopamine transporter pet data provides a specific metric for the nigral dopaminergic neuronal density.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description The loss of dopaminergic (DA) neurons in the substantia nigra (SN) is a major pathophysiological feature of patients with Parkinson's disease (PD). As nigral DA neurons contain both neuromelanin (NM) and dopamine transporter (DAT), decreased intensities in both NM-sensitive MRI and DAT PET reflect decreased DA neuronal density. This study demonstrates that a more specific metric for the nigral DA neuronal density can be derived with multimodal MRI and PET. Participants were 11 clinically diagnosed PD patients and 10 age and gender matched healthy controls (HCs). Two quantities, the NM-related index (RNM) and the binding potential of the radiotracer [18F]FE-PE2I to DAT (BPND) in SN, were measured for each subject using MRI and PET, respectively. Principal component analysis (PCA) was applied to the multimodal data set to estimate principal components. One of the components, PCP, corresponds to a basis vector oriented in a direction where both BPND and RNM increase. The ability of BPND, RNM and PCP to discriminate between HC and PD groups was compared. Correlation analyses between the motor score of the unified Parkinson's disease rating scale and each metric were also performed. PCP, BPND and RNM for PD patients were significantly lower than those for HCs (F = 16.26, P<0.001; F = 6.05, P = 0.008; F = 7.31, P = 0.034, respectively). The differential diagnostic performance between the HC and PD groups as assessed by the area under the receiver-operating characteristic curve was best for PCP (0.94, 95% CI: 0.66-1.00). A significant negative correlation was found between the motor severity score and PCp (R = -0.70, P<0.001) and RNM (R = -0.52, P = 0.015), but not for BPND (R = -0.36, P = 0.110). PCA of multimodal NM-sensitive MRI and DAT PET data provides a metric for nigral DA neuronal density that will help illuminate the pathophysiology of PD in SN. Further studies are required to explore whether PCA is useful for other parkinsonian syndromes.
url http://europepmc.org/articles/PMC4783074?pdf=render
work_keys_str_mv AT hiroshikawaguchi principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT hitoshishimada principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT fumitoshikodaka principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT masayukisuzuki principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT hitoshishinotoh principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT shigekihirano principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT jeffkershaw principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT yuichiinoue principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT masakinakamura principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT taekosasai principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT minakobayashi principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT tetsuyasuhara principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
AT hiroshiito principalcomponentanalysisofmultimodalneuromelaninmrianddopaminetransporterpetdataprovidesaspecificmetricforthenigraldopaminergicneuronaldensity
_version_ 1724967018056122368